Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension

This manuscript on endpoints incorporates the broad experience of members of Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative as an open debate platform for academia, the pharmaceutical industry and regulatory experts surrounding the future design of clinical trials in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitbon, Olivier, Nikkho, Sylvia, Benza, Raymond, (CQ) Deng, Chunqin, Farber, Harrison W., Gomberg-Maitland, Mardi, Hassoun, Paul, Meier, Christian, Pepke-Zaba, Joanna, Prasad, Krishna, Seeger, Werner, Corris, Paul A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Consensus Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682238/
https://www.ncbi.nlm.nih.gov/pubmed/33282190
http://dx.doi.org/10.1177/2045894020962960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682238/
https://www.ncbi.nlm.nih.gov/pubmed/33282190
http://dx.doi.org/10.1177/2045894020962960

Ejemplares similares